A case of erenumab, a new migraine medication, and delayed wound and bone healing after foot and ankle surgery

A case of erenumab, a new migraine medication, and delayed wound and bone healing after foot and ankle surgery

Patient selection and optimization are crucial components of successful surgery outcomes. Erenumab is a Calcitonin Gene-Related Peptide (CGRP) antagonist that was recently approved by the FDA for the treatment of migraines. CGRP is a neuropeptide implicated in migraines, but is also essential in ost...

Full description

Saved in:
Bibliographic Details
Main Authors: Timothy Cheung, DPM, PhD, CPT, Zachary Korwek, DPM, Arij Rashid, DPM, AACFAS, Rumzah Paracha, MD, Ashley Bruno, DPM, FACFAS
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Foot & Ankle Surgery: Techniques, Reports & Cases
Subjects:
Nonunion
Delayed union
Migraine
Wound healing
Bunion
Online Access:http://www.sciencedirect.com/science/article/pii/S266739672400082X
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items